Open Access
Issue
Med Sci (Paris)
Volume 36, Number 8-9, Août–Septembre 2020
Page(s) 691 - 694
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2020138
Published online 21 August 2020
  1. Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol 2020; https://doi.org/10.1038/s41579-020-0331-1. [Google Scholar]
  2. Mougari F, Guglielmetti L, Raskine L, et al. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Exp Rev Anti-Inf Ther 2016 ; 14 : 1139–1154. [CrossRef] [Google Scholar]
  3. Bernut A, Herrmann JL, Lutfalla G, Kremer L. Les cordes mycobactériennes : un nouveau moyen d’échappement au système immunitaire ?. Med Sci (Paris) 2014 ; 30 : 499–502. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Catherinot E, Roux AL, Macheras E, et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol 2009 ; 47 : 271–274. [CrossRef] [PubMed] [Google Scholar]
  5. Chalut C.. MmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteria. Tuberculosis (Edinb) 2016 ; 100 : 32–45. [CrossRef] [PubMed] [Google Scholar]
  6. Dupont C, Viljoen A, Dubar F, et al. A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus. Mol Microbiol 2016 ; 101 : 515–529. [CrossRef] [PubMed] [Google Scholar]
  7. Kozikowski A, Onajole OK, Stec J, et al. Targeting mycolic acid transport by indole-2-carboxamides for the treatment of Mycobacterium abscessus infections. J Med Chem 2017 ; 60 : 5876–5888. [CrossRef] [PubMed] [Google Scholar]
  8. Raynaud C, Daher W, Johansen MD, et al. Active benzimidazole derivatives targeting the MmpL3 transporter in Mycobacterium abscessus. ACS Inf Dis 2020; 6 : 324–37. [CrossRef] [Google Scholar]
  9. Korycka-Machała M, Viljoen A, Pawełczyk J, et al. 1H-Benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2019 ; 63 : e00441–e00419. [PubMed] [Google Scholar]
  10. Li W, Sanchez-Hidalgo A, Jones V, et al. Synergistic interactions of MmpL3 inhibitors with antitubercular compounds in vitro. Antimicrob Agents Chemother 2017 ; 61 : e02399–e02316. [PubMed] [Google Scholar]
  11. Zhang B, Li J, Yang X, et al. Crystal structures of membrane transporter MmpL3, an anti-TB drug target. Cell 2019 ; 176 : 636–48 e13. [Google Scholar]
  12. Le Moigne V, Raynaud C, Moreau F, et al. Efficacy of bedaquiline, alone or in combination with imipenem, against Mycobacterium abscessus in C3HeB/FeJ mice. Antimicrob Agents Chemother 2020; 64 : e00114–20. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.